Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage
This study has been completed.
Study NCT00198497   Information provided by ISTA Pharmaceuticals
First Received: September 13, 2005   Last Updated: January 15, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Vitreous Hemorrhage
Diabetic Retinopathy
Additional conditions recognized in this trial
Hemorrhage
Retinal Diseases
More general conditions related to this trial
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Diabetic Angiopathies
Endocrine System Diseases
Eye Diseases
Eye Hemorrhage
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
Vitrase (ovine hyaluronidase)
Sponsors listed in this trial
ISTA Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services